Individual Shareholder Meeting
Published on September 23, 2014
On October 23, 2014 at Cellectis’ headquarters in Paris.
Date: October 23, 2014
Time: 6:00 to 8:30PM
Location: Cellectis – 11 rue Watt – 75013 Paris
André Choulika, PhD, Chairman and Chief Executive Officer of Cellectis, Mathieu Simon, MD, Executive Vice President and Thierry Moulin, Chief Financial Officer, will present to the Company's individual shareholders perspectives on developing immunotherapies based on engineering CART allogeneic (UCART) lymphocytes.
Feel free to send your questions ahead of the meeting at email@example.com.
Please RSVP with:
Cellectis / Jennifer Moore firstname.lastname@example.org Phone: 01 81 69 16 00
Upon invitation – limited seats available